Latest Breaking News On - ஜான்சன் பார்வை - Page 12 : comparemela.com

Share this article Share this article SANTA ANA, Calif., April 21, 2021 /PRNewswire/  Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification innovation, the VERITAS™ Vision System 1. The high-performance phacoemulsification system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery.  (PRNewsfoto/Johnson & Johnson Vision) More than 90% of people develop cataracts by the age of 65, 2 and cataract surgery is one of the most common outpatient procedures performed today with a success rate of approximately 98%.

United statesRajeshk rajpalCenters for diseaseKellogg eye centerExchange commissionJohnson vision care incJournal of the missouri state medical associationAffairs at johnson visionJohnson johnsonmedical devices companiesVision health initiativeJohnson medical devices companiesJohnson surgical vision incChief medical officerGlobal headMedical affairsJohnson vision